Steroid dynamics in myalgic encephalomyelitis / chronic fatigue syndrome: a case-control study using ultra performance supercritical fluid chromatography tandem mass spectrometry. — CFSMEATLAS
Steroid dynamics in myalgic encephalomyelitis / chronic fatigue syndrome: a case-control study using ultra performance supercritical fluid chromatography tandem mass spectrometry.
Thomas, Natalie, Ubhayasekera, S J Kumari A, Armstrong, Christopher W et al. · Journal of translational medicine · 2025 · DOI
Quick Summary
This study looked at stress hormones (steroids) in the blood of people with ME/CFS compared to healthy controls. While the amounts of individual hormones were similar between the two groups, the researchers found that the hormones were not communicating with each other properly in ME/CFS patients—like instruments in an orchestra playing out of sync. This suggests that the body's hormone regulation system may be disrupted in ME/CFS, even when individual hormone levels appear normal.
Why It Matters
This study provides novel evidence that ME/CFS involves disrupted hormone network dynamics rather than simple deficiencies or elevations in individual hormone levels—a finding that could explain why standard hormone testing often appears 'normal' in ME/CFS patients. Understanding these network dysregulations may guide future therapeutic approaches targeting hormone coordination rather than isolated hormone replacement.
Observed Findings
Individual steroid hormone levels showed no significant differences between ME/CFS and controls after correction for multiple comparisons
Network analysis revealed 52 significant steroid-steroid correlations in controls but only 1 in ME/CFS patients
Cortisone showed markedly increased network centrality in ME/CFS (degree=7, betweenness=16.7) compared to controls
Progesterone displayed reduced network integration in ME/CFS (degree reduced from 12 to 3; eigenvector centrality reduced from 0.93 to 0.40)
Cortisol-to-pregnanolone ratio was elevated in ME/CFS, though this did not survive multiple comparison correction
Inferred Conclusions
Despite normal individual steroid concentrations, ME/CFS patients show disrupted steroid-steroid interrelationships suggesting impaired HPA axis coordination and progestogen pathway dysregulation
Hormone network analysis reveals structural reorganization in ME/CFS with altered central hub dynamics, indicating global steroid homeostatic dysregulation
The findings emphasize that hormone dysfunction in ME/CFS may manifest as network-level dyscoordination rather than simple quantitative abnormalities, requiring network-based rather than single-marker diagnostic approaches
Remaining Questions
What mechanisms drive the loss of steroid-steroid correlations and network reorganization in ME/CFS—are they primary defects or secondary responses to disease?
What This Study Does Not Prove
This study does not prove that steroid dysregulation causes ME/CFS or that correcting these hormone relationships will improve symptoms. The small sample size, modest predictive power of the steroid profile, and cross-sectional design prevent determination of causality or clinical utility. The findings describe an association and should not be interpreted as diagnostic or immediately applicable to treatment.
Tags
Symptom:Post-Exertional MalaiseFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:PEM Not DefinedSmall SampleExploratory Only